Clinical trials
Not yet recruiting Phase 1/2 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Avistone Pharmaceutical（Ningbo）Co., LTD. | 1 |
| BOE Technology Group Co., Ltd. | 1 |
| Beijing Pearl Biotechnology Limited Liability Company | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Daiichi Sankyo | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Genfleet Therapeutics (Shanghai) Inc. | 1 |
| Henan Cancer Hospital | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| LG Chem | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 23 |
| Colorectal Neoplasms | 5 |
| Lung Neoplasms | 4 |
| Endometrial Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Ovarian Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Stomach Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.